Unpacking Trump Admin Plans for Value-Based Care
Senior Policy Advisor Miranda Franco authored a Law360 article examining changes in the Center for Medicare and Medicaid Innovation's (CMMI) strategy to meet the Trump Administration's goals of enhancing Americans' health though disease prevention, informed patient choices and industry competition. Established under the Affordable Care Act, CMMI tests innovative healthcare delivery and payment models with the aim of integrating successful trials into broader Medicare and Medicaid policies. The announcement revealed the termination of several models, including Primary Care First and Maryland Total Cost of Care, to align with the administration's focus on assessment and cost savings; CMMI estimates ending these models will yield savings of around $750 million. Ms. Franco argues that despite criticism over complexity and savings, CMMI remains a pivotal player in healthcare policy, saying providers and payors should expect more market-centric reforms under new leadership while also considering rural health equity and chronic disease management.
Ms. Franco also published a Holland & Knight alert on this topic.
Related Insights
